Condition: Asthma
Interventions: Drug: CRD007; Other: Placebo
Sponsor: RSPR Pharma AB
Completed – verified November 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: CRD007; Other: Placebo
Sponsor: RSPR Pharma AB
Completed – verified November 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
Sacramento Bee ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
PR Newswire (press release) ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial …
MarketWatch (press release) ARIDOL should not be used as a stand alone test to assess asthma or as a screening test for asthma, but as part of a physician's overall assessment of asthma. The new J-code becomes effective on January 1, 2012. J-codes are used by providers to bill … |
View full post on asthma – Google News
FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial …
Kansas City Star ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
Condition: Asthma
Intervention: Other: mannitol (an airway challenge agent)
Sponsor: University of Dundee
Completed – verified March 2008
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Conditions: Asthma; Cough Variant Asthma
Interventions: Drug: high-dose methacholine challenge test; Other: mannitol challenge test
Sponsor: Queen’s University
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days